1620278-72-9 - Names and Identifiers
1620278-72-9 - Physico-chemical Properties
Molecular Formula | C22H26ClN5
|
Molar Mass | 395.94 |
Solubility | Soluble in DMSO |
Storage Condition | -20°C |
Use | TLR7/8 agonist-5d is a TLR7/8 agonist which shows prominent immunostimulatory activities. |
In vitro study | TLR7/8 agonist 1 (Compound 5d) shows prominent immunostimulatory activities. TLR7/8 agonist 1 serves as a convenient precursor for the covalent attachment of fluorophores without significant loss of activity. TLR7/8 agonist 1 retains TLR7-agonistic activity with an EC 50 of 20 nM. TLR7/8 agonist 1 (Compound 1) shows substantially different agonistic potencies in human TLR7 (50 nM) and TLR8 (55 nM) primary screens. |
1620278-72-9 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.313 ml | 11.564 ml | 23.127 ml |
5 mM | 0.463 ml | 2.313 ml | 4.625 ml |
10 mM | 0.231 ml | 1.156 ml | 2.313 ml |
5 mM | 0.046 ml | 0.231 ml | 0.463 ml |
Last Update:2024-01-02 23:10:35
1620278-72-9 - Reference Information
biological activity | TLR7/8 agonist 1 dihydrochloride is a double agonist of toll-like receptor TLR7/TLR8. |
target | TLR7/TLR8 |
in vitro study | TLR7/8 agonist 1 (Compound 5d) shows prominent immunostimulatory activities. TLR7/8 agonist 1 serves as a convenient precursor for the covalent attachment of fluorophores without significant loss of activity. TLR7/8 agonist 1 retains TLR7-agonistic activity with an EC 50 of 20 nM. TLR7/8 agonist 1 (Compound 1) shows substantially different agonistic potencies in human TLR7 (50 nM) and TLR8 (55 nM) primary screens. |
Last Update:2024-04-09 15:16:37